Feature | July 07, 2010| Dave Fornell

Big Strides Made to Expand Interventional Offerings

Three companies made significant purchases and product introductions in May and June in efforts to gain a larger share of the interventional, cath lab device market.

Combining IVUS, Therapeutic Devices

Volcano Corp. told Diagnostic and Invasive Cardiology earlier this year it plans to diversify its business from intravascular imaging systems and fractional flow reserve (FFR) catheters to interventional treatment devices. It received its first therapy device regulatory clearance in Europe for the Vibe RX, a single catheter combining intravascular ultrasound (IVUS) with an angioplasty balloon. The catheter reduces the need for multiple exchanges, helping to speed procedure times and cut costs.

The Vibe RX is the first of what the company hopes will be many image-guided therapy devices. Volcano’s initial focus is on cardiovascular applications, but it will eventually leverage the combo technology for other applications throughout the body.

The company also plans to expand its interventional offerings through partnerships with other device manufacturers. Earlier this year Volcano entered into a Japanese distribution agreement with AngioScore for its AngioSculpt PTCA scoring balloon catheter.

OCT Cleared, Then Purchased

Soon after the U.S. Food and Drug Administration (FDA) cleared LightLab Imaging’s optical coherence tomography (OCT) intravascular imaging system, St. Jude Medical purchased the company. The $90 million purchase will make St. Jude the only company in the United States to offer OCT, which provides image resolution 10 times greater than IVUS. The technology is expected to offer serious competition for IVUS makers Boston Scientific and Volcano.

St. Jude said OCT is expected to bring in an extra $20 million in revenue during the second half of 2010. The company also expects the OCT market to grow at a double-digit, compounded annual rate over the next five years. The IVUS market is estimated to be $500 million for 2010 and is growing 10 to 15 percent annually. St. Jude said the OCT coronary imaging is expected to grow at an even faster rate.

Volcano also developed an OCT system, which gained European clearance in January. The company is now awaiting FDA investigational device exemption (IDE) approval so it can start its U.S. clinical trial. Volcano hopes to release its OCT system in the United States by mid-2011.

Expanding Into the Interventional Market

Covidien Ltd. recently purchased ev3 Inc. for $2.6 billion to expand its percutaneous vascular portfolio. The company said it hopes to become a leading endovascular player in both the peripheral vascular and neurovascular markets.

Ev3 Inc. developed several technologies for the treatment of peripheral vascular and neurovascular diseases. These products include peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, flow diversion, thrombectomy catheters and occlusion balloons.

Last year, Covidien purchased VNUS Medical Technologies and Bacchus Vascular to expand its vascular interventional business. VNUS is a leading provider of medical devices and procedures for the minimally invasive treatment of venous reflux disease. Bacchus Vascular offers the Trellis thrombolysis peripheral infusion system to treat deep vein thrombosis (DVT).

Detailed information on the use of the Trellis device can be found in this issue’s story on clot busting technologies on page 6.

Related Content

Toshiba Showcases Vantage Galan 3T MRI at ISMRM 2017
News | Magnetic Resonance Imaging (MRI)| April 24, 2017
April 24, 2017 — Offering a full range of advanced clinical applications for researchers, Toshiba Medical will demons

Physicians will need to use a CMS-certified appropriate use criteria (AUC) clinical decision support software that documents the appropriateness of an imaging order to receive full reimbursement for Medicare patients starting Jan. 1, 2018.

Feature | Cardiac Imaging| April 18, 2017 | Dave Fornell
As part of U.S. healthcare reform efforts, starting Jan.
cardiac CT showing a severe right coronary artery lesion on a Toshiba Aquillion One

A cardiac CT showing a severe right coronary artery lesion on both 3-D and curved multiplanar reconstructions from a Toshiba Aquilion One CT system. The newest generation of CT scanners have very fast gantry speeds to freeze cardiac motion, improved image quality and much lower doses than previous generation scanners from a decade ago.

Feature | CT Angiography (CTA)| April 13, 2017 | Dave Fornell
Cardiac computed tomography (CT) imaging really took off a decade ago with the introduction of 64-slice scanners, whi
SCCT, Toshiba Medical, partnership, residents-in-training
News | Computed Tomography (CT)| April 05, 2017
The Society of Cardiovascular Computed Tomography (SCCT) and Toshiba Medical announced a new partnership dedicated to...
ASE, EACVI, focused update document, aortic stenosis, AS, echocardiography, new classification scheme
News | Cardiovascular Ultrasound| April 03, 2017
The American Society of Echocardiography (ASE) and the European Association of Cardiovascular Imaging (EACVI) have...
ACR Appropriateness Criteria, update, new topics, medical imaging, AUC, American College of Radiology
News | Clinical Decision Support| April 03, 2017
The newest release of American College of Radiology (ACR) Appropriateness Criteria covers 230 topics with more than 1,...
Philips, cardiology solutions, ACC.17, Azurion angiography system, iFR outcomes results, IntelliSpace Cardiovascular
News | Cardiac Imaging| March 24, 2017
At the 2017 American College of Cardiology's Annual Scientific Session & Expo (ACC.17), Philips showcased a broad...
Toshiba, Aquilion One CT, model-based iterative reconstruction, MBIR, ACC 2017, FIRST, RSNA 2017
News | Computed Tomography (CT)| March 21, 2017
March 21, 2017 — Toshiba Medical demonstrated its Forward projected model-based Iterative Reconstruction SoluTion (FI
Siemens Healthineers, ACC 2017, syngot CTO Guidance, Compressed Sensing Cardiac Cine
News | Cardiac Imaging| March 16, 2017
During the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC), March 17-19 in...
CTA, CT angiography, predict heart attacks, Radiology study
News | CT Angiography (CTA)| March 14, 2017
Noninvasive computed tomography (CT) angiography and stress tests can help predict which patients are likely to suffer...
Overlay Init